XELOX trials for Colorectal cancer

All XELOX trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying XELOX for Colorectal cancer

• CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
  NCT06242418 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 9 locations
• LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
  NCT06848465 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
  NCT05228431 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
  NCT03671252 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study XELOX for Colorectal cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.